SEP 9, 2026 · PHASE 1 TRIAL
A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants
ClinicalTrials.gov
This is a Phase 1 clinical trial registry record with no results posted; it describes a planned safety and drug-drug interaction study in a small healthy population.
Reported
Planned enrollment40
PhasePhase 1
Study durationup to 111 days